Cintia Piccina - 31 Jan 2022 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Chief Commercial Officer
Signature
/s/ Cintia Piccina
Issuer symbol
ADAP
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 20:05:29 UTC
Next filing
01 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +3,376,992 $0.000000 3,376,992 31 Jan 2022 Ordinary Shares 3,376,992 $0.4500 Direct F1, F2
transaction ADAP Option to purchase Ordinary Shares Award $0 +754,200 $0.000000 754,200 31 Jan 2022 Ordinary Shares 754,200 $0.001300 Direct F3, F4, F5
transaction ADAP Option to purchase Ordinary Shares Award $0 +335,184 $0.000000 335,184 31 Jan 2022 Ordinary Shares 335,184 $0.001300 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.33 based on an exchange rate of U.S.$1.34145 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F2 Exercisable as to 844,248 Ordinary Shares on January 31, 2023 and will be exercisable as to the remainder in monthly installments of 70,350 Ordinary Shares on the last day of each month from February 28, 2023 through December 31, 2025 and 70,494 Ordinary Shares on January 31, 2026.
F3 The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1.34145 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F4 Exercisable as to 188,550 Ordinary Shares on January 31, 2023 and will be exercisable as to the remainder in annual installments of 188,550 Ordinary Shares on the thirty-first of each January from January 31, 2024 through January 31, 2026.
F5 The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable.
F6 The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1.34145 to GBP1.00. The actual exercise price will be the pounds sterling amount.